Clinical trial

Sitagliptin and Glucagon Counterregulation

NCT02256189

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2015-04-01

PhasePHASE4

Study timeline

Study start (actual)2015-04-01Date precision: month

Registry last updated2019-02-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetesunresolved

Interventions

SitagliptinDRUG · verified · RxNorm: sitagliptin

PlaceboDRUG

Sponsors & collaborators

Lund Universitylead sponsor

Merck Sharp & Dohme LLCcollaborator

Mapped research locations

MalmöSweden1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02256189 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.